RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
Cuidado con sacar conclusiones sobre cuál es más eficaz en análisis retrospectivos de bases de datos administrativas....Se necesita evidencia de estudios controlados prospectivos para ello... https://t.co/dxO7z6N4YR
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
RT @mendez_bailon: Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más segu…
Anticoagulacion oral en fibrilacion auricular y deterioro de la función renal. Dabigatran y Rivaroxaban parecen más seguros que warfarina. Apixaban mantiene un efecto neutro. #SEMItuit @IcaSemes @UMIPIC #AFib https://t.co/YmhNg9IC5V
Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation are improved by NOACS over warfarin https://t.co/4iwqQQdJkm
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @Manugrillo2: Renal function decline is common among patients with AF treated with oral anticoagulant agents. #NOACs, particularly dabig…
Renal function decline is common among patients with AF treated with oral anticoagulant agents. #NOACs, particularly dabigatran and rivaroxaban, may be associated with lower risks of adverse renal outcomes than warfarin https://t.co/b1bgb3GsDb https://t.co
RT @almucastro01: ACOD y ER: menos riesgo de progresión q con warfarina. @jlgorriz te viene genial este paper para CARDIOREN https://t.co…
RT @almucastro01: ACOD y ER: menos riesgo de progresión q con warfarina. @jlgorriz te viene genial este paper para CARDIOREN https://t.co…
ACOD y ER: menos riesgo de progresión q con warfarina. @jlgorriz te viene genial este paper para CARDIOREN https://t.co/bTnHdqaTh9
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @AlanaziZaid: Renal function decline is common among patients with AF treated with oral anticoagulant agents. NOACs, particularly dabiga…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
https://t.co/xsD2ybv0Sw @CardioIAN
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
@bloodmed, is Neil Smith on twitter? https://t.co/hZWIR04eCk
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
Renal deterioriation common in #AFIB, less with #NOAC treatment? #cardiology #Cardiotwittter https://t.co/0qnn6LGvKe https://t.co/rWQ22U2xNf
RT @torresviera: NOACs, particularly dabigatran and rivaroxaban, may be associated with lower risks of adverse renal outcomes than warfarin…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @torresviera: NOACs, particularly dabigatran and rivaroxaban, may be associated with lower risks of adverse renal outcomes than warfarin…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @heralv1985: Siempre complicándonos la FA en el tratamiento de los pacientes... Otro reto más. https://t.co/oDKuZBW3DO
RT @AlanaziZaid: Renal function decline is common among patients with AF treated with oral anticoagulant agents. NOACs, particularly dabiga…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
Renal function decline is common among patients with AF treated with oral anticoagulant agents. NOACs, particularly dabigatran and rivaroxaban, may be associated with lower risks of adverse renal outcomes than warfarin. https://t.co/rJNIrO5LUY https://t.co
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
NOACs https://t.co/jFgBcin5OE
NOACs, particularly dabigatran and rivaroxaban, may be associated with lower risks of adverse renal outcomes than warfarin. https://t.co/9kLGXHX3Yb
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
Siempre complicándonos la FA en el tratamiento de los pacientes... Otro reto más. https://t.co/oDKuZBW3DO
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…
RT @JACCJournals: Renal function decline is common in patients w/ Afib. Which anticoagulants have better renal outcomes? #JACC https://t.co…